Breast Cancer Trial, Recruiting NCT06995118 Sponsor: Du Zhenggui Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT06995118
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman between 18 and 70 years old (including those aged exactly 18 or 70)
  • You are a candidate for a specific type of keyhole (endoscopic) breast removal surgery that preserves the nipple, with immediate breast reconstruction using an implant, on one or both breasts
  • A procedure to enhance the opposite breast at the same time may also be allowed
  • You have been diagnosed with a common type of breast cancer (such as ductal carcinoma in situ, invasive ductal carcinoma, or invasive lobular carcinoma), confirmed before surgery, or you qualify for preventive breast removal surgery
  • If you have breast cancer, your tumor is no larger than 5 cm before surgery (or after any pre-surgery chemotherapy if that applies), and there is no sign that the cancer has spread to the nipple, skin, chest wall, or other parts of the body
  • You are willing to give your informed consent to take part

Who may not be able to join:

  • You have had open breast surgery in the past year (minor biopsy procedures do not count)
  • You were diagnosed with breast cancer while pregnant or breastfeeding
  • You have scar tissue under the nipple area caused by radiation therapy
  • Your breast cancer has spread to other parts of the body (stage M1/metastatic)
  • You have serious health conditions that make general anaesthesia or surgery unsafe
  • Your Body Mass Index (BMI) is 40 or higher (a measure of body weight relative to height)
  • Your long-term blood sugar control reading (HbA1c) is above 7.5% (confirm with trial site)
  • You have a weakened immune system
  • You currently smoke 20 or more cigarettes per day
  • You are already taking part in another clinical trial that may conflict with this one

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 5 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 13880768222

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Du Zhenggui
Registry
ClinicalTrials.gov
Start date
17 June 2025
Est. completion
1 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Operative time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov